| Issuer / Guarantor | Viking Therapeutics Inc |
|---|---|
| Size | USD 200mn |
| Type | Convertible |
| Leads | Morgan Stanley, JP Morgan |
| Maturity | 15 Oct 2032 (6 years) |
| Coupon | 1.75 - 2.25% |
| Premium | 42.5 - 47.5% |
| Calls | NC3; PC @ 130% w table MW |
| Puts | t/o @ 100% |
| Div protection | Ratio adjustment (Full) |
| T/o protection | Make-whole table |
| CoCo | 130% to Jul 2032 (5.8 yrs) |
| Announced | 23 Sep 2026 |